ProCE Banner Activity

ROSE2: Phase II Trial of Obicetrapib + Ezetimibe as an Adjunct to High-Intensity Statin Therapy

Capsule Summary
Conference Coverage
Slideset

Downloadable deck reviewing key takeaways from the ROSE2 trial.

Released: June 08, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics